Nurix Therapeutics Inc.
NRIX | NASDAQ
$25.41
-$0.03 (-0.12%)
At close: Sep 21, 2026, 4:00 PM ET
$25.40
-$0.01 (-0.04%)
Pre-market:
Sep 22, 2026, 7:15 AM ET
TTM Period Ending | Q2 2026 May 30, 2026 | Q1 2026 Feb 27, 2026 | Q4 2025 Nov 29, 2025 | Q3 2025 Aug 30, 2025 | Q2 2025 May 30, 2025 | Q1 2025 Feb 27, 2025 | Q4 2024 Nov 29, 2024 | Q3 2024 Aug 30, 2024 | Q2 2024 May 30, 2024 | Q1 2024 Feb 28, 2024 | Q4 2023 Nov 29, 2023 | Q3 2023 Aug 30, 2023 | Q2 2023 May 30, 2023 | Q1 2023 Feb 27, 2023 | Q4 2022 Nov 29, 2022 | Q3 2022 Aug 30, 2022 | Q2 2022 May 30, 2022 | Q1 2022 Feb 27, 2022 | Q4 2021 Nov 29, 2021 | Q3 2021 Aug 30, 2021 | Q2 2021 May 30, 2021 | Q1 2021 Feb 27, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 36.77M | 71.78M | 83.98M | 83.69M | 88.38M | 56.42M | 54.55M | 56.42M | 62.3M | 80.89M | 76.99M | 68.61M | 60.94M | 41.69M | 38.63M | 39.24M | 38.7M | 34.36M | 29.75M | 29.04M | 22.88M | 19.97M |
Cost of Revenue | 93.77M | 171.86M | 157.39M | 219.98M | 270.46M | 241.29M | 221.63M | 204.12M | 196.5M | 193.34M | 189.15M | 185.54M | 185.45M | 187.18M | 184.5M | 174.92M | 158.07M | 136.57M | 116.43M | 100.35M | 88.38M | 76.53M |
Gross Profit | -57M | -100.09M | -73.41M | -136.3M | -182.08M | -184.87M | -167.08M | -147.7M | -134.19M | -112.45M | -112.16M | -116.93M | -124.51M | -145.49M | -145.87M | -135.68M | -119.37M | -102.21M | -86.68M | -71.31M | -65.51M | -56.56M |
Operating Income | -361.18M | -315.3M | -285.67M | -267.23M | -230.45M | -230.67M | -213.03M | -193.7M | -179.11M | -157.33M | -155.06M | -158.42M | -165.13M | -184.08M | -183.87M | -173.13M | -155.41M | -136.11M | -117.89M | -99.94M | -90.14M | -76.95M |
Interest Income | 19.56M | 20.78M | 21.97M | 23.21M | 23.98M | 22.45M | 19.73M | 16.99M | 14.28M | 12.69M | 11.12M | 9.71M | 7.69M | 5.52M | 3.51M | 1.83M | 859K | 716K | 823K | 663K | 1.3M | 1.35M |
Pretax Income | -341.62M | -294.52M | -263.7M | -244.02M | -206.47M | -208.22M | -193.3M | -176.71M | -164.82M | -144.64M | -143.95M | -148.71M | -157.44M | -178.56M | -180.36M | -171.3M | -154.55M | -135.39M | -117.06M | -99.28M | -88.84M | -75.6M |
Net Income | -341.35M | -295.28M | -264.46M | -244.79M | -207.32M | -208.4M | -193.57M | -176.98M | -165M | -144.73M | -143.95M | -148.71M | -157.44M | -178.56M | -180.36M | -171.35M | -154.47M | -135.45M | -117.19M | -99.41M | -89.09M | -55.13M |
Selling & General & Admin | 57.01M | 55.7M | 52.74M | 49.81M | 48.37M | 45.8M | 45.94M | 46.01M | 44.91M | 44.88M | 42.9M | 41.49M | 40.61M | 38.59M | 38M | 37.45M | 36.04M | 33.9M | 31.2M | 28.64M | 24.63M | 20.39M |
Research & Development | 338.81M | 329.26M | 314.78M | 301.1M | 270.46M | 241.29M | 221.63M | 204.12M | 196.5M | 193.34M | 189.15M | 185.54M | 185.45M | 187.18M | 184.5M | 174.92M | 158.07M | 136.57M | 116.43M | 100.35M | 88.38M | 76.53M |
Other Expenses | -91.65M | -169.74M | -155.27M | -219.98M | -270.46M | -241.29M | -221.63M | -204.12M | -196.5M | -193.34M | -189.15M | -185.54M | -185.45M | -187.18M | -184.5M | -174.92M | -158.07M | -136.57M | -116.43M | -100.35M | -88.38M | -76.53M |
Operating Expenses | 304.18M | 215.21M | 212.26M | 130.93M | 48.37M | 45.8M | 45.94M | 46.01M | 44.91M | 44.88M | 42.9M | 41.49M | 40.61M | 38.59M | 38M | 37.45M | 36.04M | 33.9M | 31.2M | 28.64M | 24.63M | 20.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 397.95M | 387.08M | 369.65M | 350.92M | 318.84M | 287.09M | 267.58M | 250.13M | 241.41M | 238.22M | 232.05M | 227.03M | 226.06M | 225.77M | 222.49M | 212.37M | 194.11M | 170.47M | 147.64M | 128.98M | 113.01M | 96.92M |
Income Tax Expense | -271K | 760K | 760K | 768K | 850K | 180K | 270K | 262K | 180K | 90K | n/a | n/a | n/a | n/a | n/a | 44K | -79K | 60K | 131K | 128K | 251K | -20.48M |
Shares Outstanding (Basic) | 111.08M | 110.07M | 95.09M | 84.16M | 83.88M | 83.56M | 78.41M | 72.78M | 62.38M | 54.9M | 54.67M | 54.39M | 54.26M | 54.03M | 53.94M | 50.87M | 44.9M | 44.69M | 44.55M | 44.37M | 43.8M | 38.78M |
Shares Outstanding (Diluted) | 111.08M | 110.07M | 95.09M | 84.16M | 83.88M | 83.56M | 78.41M | 72.78M | 62.38M | 54.9M | 54.67M | 54.39M | 54.26M | 54.03M | 53.94M | 50.87M | 44.9M | 44.69M | 44.55M | 44.37M | 43.8M | 38.78M |
EPS (Basic) | -3.45 | -3.16 | -3.04 | -2.97 | -2.61 | -2.80 | -2.89 | -2.91 | -2.92 | -2.61 | -2.50 | -2.50 | -2.70 | -3.30 | -3.60 | -3.68 | -3.45 | -3.05 | -2.73 | -2.39 | -2.83 | -2.01 |
EPS (Diluted) | -3.45 | -3.16 | -3.04 | -2.97 | -2.61 | -2.80 | -2.89 | -2.91 | -2.92 | -2.61 | -2.50 | -2.50 | -2.70 | -3.30 | -3.60 | -3.68 | -3.45 | -3.05 | -2.73 | -2.39 | -2.83 | -2.01 |
EBITDA | -323.58M | -274.24M | -244.84M | -233.18M | -198.24M | -199.9M | -185.28M | -169.41M | -157.96M | -138.22M | -137.82M | -142.69M | -151.91M | -173.65M | -176.21M | -166.81M | -150.78M | -132.43M | -114.76M | -97.23M | -87.65M | -74.62M |
EBIT | -341.62M | -294.52M | -263.7M | -244.02M | -206.47M | -208.22M | -193.3M | -176.71M | -164.82M | -144.64M | -143.95M | -148.71M | -157.44M | -178.56M | -180.36M | -171.3M | -154.55M | -135.56M | -117.55M | -99.9M | -90.14M | -76.95M |
Depreciation & Amortization | 18.04M | 20.28M | 18.86M | 10.84M | 8.24M | 8.32M | 8.02M | 7.3M | 6.86M | 6.43M | 6.13M | 6.02M | 5.52M | 4.91M | 4.15M | 4.49M | 3.78M | 3.14M | 2.79M | 2.68M | 2.48M | 2.33M |
Add to Watchlist
Select watchlists to add or remove NRIX